Adaptango Performance PRocess for Older Adults Community reHabilitation
- NCT ID
- NCT07824128
- Registry status
- Not yet recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- Emory University
- Conditions
- Mild Cognitive Impairment, Old Age; Dementia, Parkinson Disease
Overview
ClinicalTrials.gov lists this study as Not yet recruiting.
Official title: Community-based Participatory Evaluation Studies on a Partnered Dance Program for Adults With Neurodegenerative Disease
Enrollment: 120 participants (Estimated).
What is being studied
- Other: Adaptango Performance Process (APP) program
Who may be eligible
- Ages
- 18 Years to no maximum
- Sex
- All
- Healthy volunteers accepted
- Yes
ClinicalTrials.gov lists the following eligibility criteria.
Study locations
1 study location is listed.
Site recruitment status is not specified in the registry data for these locations.
Countries: United States
- Georgia, United States: 1
Sample of listed locations
- Emory University, Executive Park, Wesley Woods — Atlanta, Georgia, 30329, United States — Site recruitment status not specified in the registry data
Study details
- Start date
- October 1, 2026
- Primary completion date
- September 1, 2029
- Completion date
- September 1, 2029
- First posted
- September 17, 2026
- Collaborators
- National Endowment for the Arts, United States
Source and update information
- Source
- ClinicalTrials.gov
- NCT ID
- NCT07824128
- Registry last updated
- September 17, 2026
- QualifiedStudies registry data refreshed
- September 28, 2026
- QualifiedStudies record fetched
- September 28, 2026
View NCT07824128 on ClinicalTrials.gov
Trial information can change. Confirm current study details with the study team or the registry.
About joining clinical research
Find clinical trials you may match with
QualifiedStudies can help you search for research opportunities related to your health. Availability of this specific study through QualifiedStudies has not been established.
Find clinical trials you may match with | Alzheimers Disease studies | Clinical trial FAQ